Passarini Blog
Celebrating 15 Years of Innovation and Excellence with Passarini Group!
Celebrating 15 Years of Innovation and Excellence with Passarini Group! It is with great enthusiasm that we share with you an extraordinary journey of 15 years of innovation, excellence, and success with Passarini Group! Throughout this trajectory, we have proudly served our friends, clients, and [...]
Anvisa approves Strategic Plan for the 2024-2027 cycle
Anvisa approves Strategic Plan for the 2024-2027 cycle The National Health Surveillance Agency (Anvisa) is the regulatory body responsible for health regulation in Brazil, working to protect and promote the health of the population. To fulfill its mission, Anvisa develops and implements strategic plans that [...]
RDC 830/2023 New Regulations for Medical Devices
RDC 830/2023 comes into force from june 1, 2024 RDC 830/2023, provides for the risk classification notification and registration regimes, and labeling requirements and instructions for in vitro diagnosis, including their instruments, comes into force from the 1st of june 2024. With the publication of [...]
Launch of the New Brand – Passarini Europe Solutions
Passarini Europe Solutions: Expanding Horizons to Better Serve Your Business Passarini Group is honored to officially announce the launch of our newest venture: Passarini Europe Solutions! This is an exciting milestone in our journey, which reflects our unwavering commitment to excellence in regulatory advice and [...]
Challenges in Searching for Equivalent Articles
Location of Articles, Challenges, and Requirements In the quest for useful articles in clinical evaluation, frequent challenges arise. Our podcast delves into this universe to help answer important questions: where to find these articles and how to determine if they are truly valuable? In each [...]
Unraveling Equivalence in Clinical Evaluation
Unraveling Equivalence in Clinical Evaluation: Exploring the 2nd Episode of the Passarini Group Podcast We are thrilled to present the second episode of our podcast series in partnership with GRINN, focusing on a crucial theme: "EQUIVALENCE IN CLINICAL EVALUATION PROCESSES." In this episode, we delve [...]
